Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 16, Issue SUPPL. 1, 2006, Pages 35-40

  Deffieux, X ^a   Castaigne, D ^a   Pomel, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cytoreduction; Laparoscopy; Ovarian carcinoma; Peritoneal carcinomatosis

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CARCINOMATOSIS; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAPHRAGM MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LAPAROSCOPY; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; SMALL INTESTINE CANCER;

ADENOCARCINOMA; ADULT; AGED; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PATIENT SELECTION;

EID: 33645336041     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00323.x     Document Type: Article

References (24)

1. Hoskins WJ McGuire WP Brady MF et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994 170 974 80.
2. Bristow RE Tomacruz RS Armstrong DK Trimble EL Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002 20 1248 59.
3. Eisenkop SM Friedman RL Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998 69 103 8.
4. Eisenkop SM Spirtos NM Friedman RL Lin WC Pisani AL Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003 90 390 6.
5. Heintz AP Hacker NF Berek JS Rose TP Munoz AK Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 1986 67 783 8.
6. Ansquer Y Leblanc E Clough K et al. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer 2001 91 2329 34.
7. Leblanc E Querleu D Narducci F Occelli B Papageorgiou T Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol 2004 94 624 9.
8. Tozzi R Kohler C Ferrara A Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol 2004 93 199 203.
9. Manolitsas TP Fowler JM. Role of laparoscopy in the management of the adnexal mass and staging of gynecologic cancers. Clin Obstet Gynecol 2001 44 495 521.
10. Vergote I De Wever I Decloedt J Tjalma W Van Gramberen M van Dam P. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin Oncol 2000 27 3 Suppl. 7 31 6.
11. Fagotti A Fanfani F Ludovisi M et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol 2005 96 729 35.
12. Elias D Lasser P Reynard B Ducreux M Pocard M. Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects. J Chir. 2003 140 270 6.
13. Fanfani F Ferrandina G Corrado G et al. Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients. Oncology 2003 65 316 22.
14. Pomel C Appleyard TL Gouy S Rouzier R Elias D. The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005 31 540 3.
15. Benedet JL Bender H Jones HIII Ngan HY Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000 70 209 62.
16. Abu-Rustum NR Barakat RR Siegel PL Venkatraman E Curtin JP Hoskins WJ. Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?. Obstet Gynecol 1996 88 4 Pt 1 549 53.
17. Clough KB Ladonne JM Nos C Renolleau C Validire P Durand JC. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study. Gynecol Oncol 1999 72 411 7.
18. Nelson BE Rosenfield AT Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993 11 166 72.
19. Childers JM Aqua KA Surwit EA Hallum AV Hatch KD. Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet Gynecol 1994 84 765 9.
20. Ziprin P Ridgway PF Peck DH Darzi AW. The theories and realities of port-site metastases: a critical appraisal. J Am Coll Surg 2002 195 395 408.
21. Curet MJ. Port site metastases. Am J Surg 2004 187 705 12.
22. 2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. Gynecol Oncol 2003 90 431 4.
23. Abu-Rustum NR Rhee EH Chi DS Sonoda Y Gemignani M Barakat RR. Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease. Obstet Gynecol 2004 103 480 7.
24. Lelievre L Paterlini-Brechot P Camatte S et al. Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells. Int J Gynecol Cancer 2004 14 229 33.